Anna Azvolinsky, PhD

Anna Azvolinsky, PhD

Freelance Science Writer and Cancer Network Contributor.

Follow Her on Twitter

Posts by Author

A systematic, best-practice approach to colorectal surgery can decrease the risk of surgical site infections, according to a new study.

The adoption of robot-assisted radical prostatectomy is on the rise in the United States, according to the results of a retrospective study.

Researchers have developed a preliminary test using blood and saliva samples to detect disease recurrence in patients with HPV-related head and neck cancer.

Overweight and obese women with estrogen receptor (ER)-positive breast cancer may benefit from daily non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin.

A new study finds that a moderate amount of regular exercise, such as walking daily, results in a lower risk of invasive breast cancer among postmenopausal women.

A large European study found that PSA screening reduces prostate cancer deaths, but that these benefits do not outweigh the harms of overtreatment.

A mutation in the PALB2 gene sharply increases the risk of breast cancer and confers a lifetime risk similar to that of BRCA2 mutation carriers, according to a new study.

A comprehensive analysis of studies and trials suggests the cancer prevention benefits of a daily aspirin for at least 5 years outweigh the potential harms.

Adding either carboplatin or bevacizumab to a neoadjuvant regimen increased rates of pathologic complete response in triple-negative breast cancer patients.

Women who have recently used high-estrogen birth control pills may be at a higher risk for developing breast cancer, according to a new study.


By clicking Accept, you agree to become a member of the UBM Medica Community.